Evidence
J Clin Exp Hepatol. 2024 May-Jun;14(3):101339. doi: 10.1016/j.jceh.2023.101339. Epub 2023 Dec 21.
ABSTRACT
Systemic lupus erythematosus (SLE) is a common multisystem disease characterised by a wide variety of presentation patterns and complex manifestations. As a lymphoid organ, the liver plays an important role in the immune response and is a target of autoimmune responses.1 SLE can affect the liver in approximately 25-60 % of patients during their disease course.2,3 Liver dysfunction and SLE can present with complicated differential diagnoses. Liver dysfunction in SLE is usually mild and rarely leads to advanced liver diseases such as cirrhosis and liver failure.4,5 Liver dysfunction in SLE is usually caused by non-SLE-related causes such as drug toxicity, fatty liver, alcoholism, and associated autoimmune hepatitis. However, primary liver involvement in SLE is also well-recognised. Patients with SLE who present with acute liver failure are rare. We report a rare case of SLE-associated acute severe liver injury along with a literature review.
PMID:38264573 | PMC:PMC10801300 | DOI:10.1016/j.jceh.2023.101339
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Severe Acute Liver Injury: First Manifestation of Systemic Lupus Erythematosus
🌐 90 Days
VR Related Evidence Matrix
- Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
- Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
- Lessons into lupus pathogenesis from inborn errors of immunity
- Neuropsychiatric Systemic Lupus Erythematosus: Molecules Involved in Its Imunopathogenesis, Clinical Features, and Treatment
- Inflammatory liver diseases and susceptibility to sepsis
- Mitochondrial dysfunction: A promising therapeutic target for liver diseases
- The role of Sirtuin 2 in liver - An extensive and complex biological process
- Neuropsychiatric symptoms in Systemic Lupus Erythematosus: mixed methods analysis of patient-derived attributional evidence in the international INSPIRE project
- The double roles of T cell-mediated immune response in the progression of MASLD
- Progress in the Correlation Between Inflammasome NLRP3 and Liver Fibrosis
- MAFLD as part of systemic metabolic dysregulation
- MAFLD as part of systemic metabolic dysregulation
- COVID-19 in Individuals with Chronic Liver Diseases
- Research progress in the regulation of pathogenesis and the transformation of chronic liver disease by short-chain fatty acids
- Occult liver disease: a multinational perspective
- Epidemiological characteristics of inpatients with liver failure at the Beijing You'an Hospital from 2012 to 2021
- The role of sirtuin1 in liver injury: molecular mechanisms and novel therapeutic target
- Antidepressants in People With Chronic Liver Disease and Depression: When Are They Warranted and How to Choose the Suitable One?
- Comparison of a Novel Score "NOD-ACLF" to Other Established Prognostic Scores for Prediction of Mortality in APASL-ACLF Patients: A Cohort Study from a Tertiary Care Center of North India
- Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics
- Metabolomics profiling reveals low blood tyrosine levels as a metabolic feature of newborns from systemic lupus erythematosus pregnancies
- Liver involvement in presence of heart disease and heart involvement in presence of liver disease: a conundrum
- Recruitment or activation of mast cells in the liver aggravates the accumulation of fibrosis in carbon tetrachloride-induced liver injury
- Chronic liver disease and management with silymarin: an introductory review of a clinical case collection
- Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
- Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
- Incretin-based investigational therapies for the treatment of MASLD/MASH
- Therapeutic potential of oleanolic acid in liver diseases
- Dietary and pharmacological treatment in patients with metabolic-dysfunction associated steatotic liver disease
- Serum S100A8/A9 and MMP-9 levels are elevated in systemic lupus erythematosus patients with cognitive impairment
- Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease
- Interleukins in liver disease treatment
- Association of metabolic-dysfunction associated steatotic liver disease with polycystic ovary syndrome
- Clinicopathological features of Sjogren's syndrome complicated with liver injury
- Associations of dietary sugars with liver stiffness in Latino adolescents with obesity differ on PNPLA3 and liver disease severity
- Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome
- APASL clinical practice guidelines on the management of acute kidney injury in acute-on-chronic liver failure
- Co-Morbid Hypothyroidism and Liver Dysfunction: A Review
- Increased Risk of Colorectal Adenomas with Metabolic-Associated Fatty Liver Disease Components
- Choosing Appropriate Nutritional Therapy for Patients With Anorexia Nervosa Exhibiting Liver Dysfunction: A Case Report
- Ocular manifestations of liver disease: an important diagnostic aid
- Ocular manifestations of liver disease: an important diagnostic aid
- Puerarin protects the fatty liver from ischemia-reperfusion injury by regulating the PI3K/AKT signaling pathway
- Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12
- Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12
- Glycyrrhizin and the Related Preparations: An Inspiring Resource for the Treatment of Liver Diseases
- Metabolic Disorders in Liver Transplant Recipients: The State of the Art
- Compromised very-low density lipoprotein induced polyunsaturated triglyceride accumulation in N-nitrosodiethylamine-induced hepatic steatosis
- Metabolic disease and the liver: A review
- The Impact of Probiotic Bifidobacterium on Liver Diseases and the Microbiota
- Cardiovascular disease in patients with metabolic dysfunction-associated steatohepatitis compared with metabolic dysfunction-associated steatotic liver disease and other liver diseases: A systematic review
- Cardiovascular disease in patients with metabolic dysfunction-associated steatohepatitis compared with metabolic dysfunction-associated steatotic liver disease and other liver diseases: A systematic review
- Role of Angiotensin II in Non-Alcoholic Steatosis Development
- From Liver to Brain: How MAFLD/MASLD Impacts Cognitive Function
- Efficacy of Yttrium-90 Transarterial Radioembolisation in Advanced Hepatocellular Carcinoma: An Experience With Hybrid Angio-Computed Tomography and Glass Microspheres
- Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: A multicenter cross sectional-study
- Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: A multicenter cross sectional-study
- Interaction of 5-HTTLPR and SLE disease status on resting-state brain function
- Liver-derived extracellular vesicles improve whole-body glycaemic control via inter-organ communication
- Regulatory pathways and therapeutic potential of PDE4 in liver pathophysiology
- Associations of severe liver diseases with cataract using data from UK Biobank: a prospective cohort study
- Hepatocellular Carcinoma in Ceará: Epidemiology and Treatment in a Reference Liver Transplant Center in Northeast Brazil
- The role of PI3k/AKT signaling pathway in attenuating liver fibrosis: a comprehensive review
- Histological characteristics in patients admitted to the hospital with alcoholic hepatitis complicated by acute-on-chronic liver failure
Evidence Blueprint
Severe Acute Liver Injury: First Manifestation of Systemic Lupus Erythematosus
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Severe Acute Liver Injury: First Manifestation of Systemic Lupus Erythematosus
🌐 365 Days
VR Related Evidence Matrix
- Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
- Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
- Lessons into lupus pathogenesis from inborn errors of immunity
- Neuropsychiatric Systemic Lupus Erythematosus: Molecules Involved in Its Imunopathogenesis, Clinical Features, and Treatment
- Doubtful Clinical Value of Subtyping Anti-U1-RNP Antibodies Regarding the RNP-70 kDa Antigen in Sera of Patients with Systemic Lupus Erythematosus
- Inflammatory liver diseases and susceptibility to sepsis
- Organ dysfunction and failure in liver disease
- Post-COVID-19 depression and anxiety in patients with systemic lupus erythematosus
- Mitochondrial dysfunction: A promising therapeutic target for liver diseases
- Metabolism-related signalling pathways involved in the pathogenesis and development of metabolic dysfunction-associated steatotic liver disease
- The role of Sirtuin 2 in liver - An extensive and complex biological process
- Implications of Inflammatory Processes on a Developing Central Nervous System in Childhood-onset Systemic Lupus Erythematosus
- Neuropsychiatric symptoms in Systemic Lupus Erythematosus: mixed methods analysis of patient-derived attributional evidence in the international INSPIRE project
- Study of Renal Dysfunction in Alcoholic Liver Disease
- COVID-19-induced liver injury in infants, children, and adolescents
- The double roles of T cell-mediated immune response in the progression of MASLD
- Lithium Toxicity - A Chameleon to Gastrointestinal Vasculitis as an Initial Presenter of Systemic Lupus Erythematosus
- Progress in the Correlation Between Inflammasome NLRP3 and Liver Fibrosis
- MAFLD as part of systemic metabolic dysregulation
- MAFLD as part of systemic metabolic dysregulation
- The correlation of anxiety and depression with C3 and C4 Levels and systemic lupus erythematosus activity
- COVID-19 in Individuals with Chronic Liver Diseases
- MASLD: a systemic metabolic disorder with cardiovascular and malignant complications
- Metabolic Dysfunction-Associated Steatotic Liver Disease: A State-of-the-Art Review
- COVID-19 and liver injury: Pathophysiology, risk factors, outcome and management in special populations
- Frontiers of Collaboration between Primary Care and Specialists in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review
- Research progress in the regulation of pathogenesis and the transformation of chronic liver disease by short-chain fatty acids
- Cellular senescence in liver diseases: From mechanisms to therapies
- Multiple Dimensions of using Mesenchymal Stem Cells for Treating Liver Diseases: From Bench to Beside
- Natural products target glycolysis in liver disease
- Novel treatment of acute and acute-on-chronic liver failure: Interleukin-22
- Occult liver disease: a multinational perspective
- Metabolic dysfunction-associated steatotic liver disease: Where does non-alcoholic fatty liver disease in liver transplant recipients fit in this new definition?
- Dissecting the potential role of ferroptosis in liver diseases: an updated review
- Epidemiological characteristics of inpatients with liver failure at the Beijing You'an Hospital from 2012 to 2021
- Complex relationships between inflammatory manifestations/type 1 and type 2 symptoms in systemic lupus erythematosus: A narrative literature review
- The role of sirtuin1 in liver injury: molecular mechanisms and novel therapeutic target
- Antidepressants in People With Chronic Liver Disease and Depression: When Are They Warranted and How to Choose the Suitable One?
- Integrating spiritual disposition intervention into behavioral medicine: A case report on systemic lupus erythematosus from India
- How non-alcoholic fatty liver disease and cirrhosis affect the heart
- Extracellular Vesicles and Fatty Liver
- Fibroprogression and Cirrhosis Occurring in Living Liver Donor: First Case Report
- Comparison of a Novel Score "NOD-ACLF" to Other Established Prognostic Scores for Prediction of Mortality in APASL-ACLF Patients: A Cohort Study from a Tertiary Care Center of North India
- Effect of the nomenclature of non-alcoholic fatty liver disease on diagnosis and treatment of fatty liver disease concomitant with other liver diseases
- Management of the acute on chronic liver failure in the intensive care unit
- Statins are associated with a decreased risk of severe liver disease in individuals with non-cirrhotic chronic liver disease
- Liver disease during the pandemic of COVID-19 infection: prediction of the course and tactics of management: A review
- Research progress of celastrol on the prevention and treatment of metabolic associated fatty liver disease
- Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics
- Liver Injury and Regeneration: Current Understanding, New Approaches, and Future Perspectives
- The Prothrombotic Tendency of Metabolic-Associated Fatty Liver Disease
- Acute liver failure and aplastic crisis due to anorexia nervosa in an adolescent girl: a case report
- Investigating the correlation between COVID-19 and the progression of chronic liver disease
- Mononuclear myeloid-derived suppressor cells expansion is associated with progression of liver failure in patients with acute decompensation of cirrhosis
- Fatty liver and celiac disease: Why worry?
- Liver sinusoidal endothelial transcription factors in metabolic homeostasis and disease
- Metabolomics profiling reveals low blood tyrosine levels as a metabolic feature of newborns from systemic lupus erythematosus pregnancies
- The Value of Liver Biopsy and Histology in Liver Disease Diagnosis and Patient Care-a Pragmatic Prospective Clinical Practice Study
- A Patient with Alcoholic Liver Disease Reports for Treatment of Dentoalveolar Abscess in Relation to Maxillary Left Molar
- Centrally acting ACE inhibitor (cACEi) and angiotensin receptor blocker (cARB) use and cognitive dysfunction in patients with SLE
- Cardiovascular disease risk perceptions and influencing factors among Chinese systemic lupus erythematosus patients
- Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity
- Corrigendum to "SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease" [J Hepatol 80 (2024) 10-19]
- Liver involvement in presence of heart disease and heart involvement in presence of liver disease: a conundrum